Idelalisib Completed Phase 1 Trials for Mantle Cell Lymphoma (MCL) / Follicular Lymphoma (FL) / Follicular Lymphoma, Mantle Cell Lymphoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02603445Study of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCL